Global Drug Discovery Services market outlook 2024, Forecast To 2033
4 Mar, 2024
The drug discovery services market size has grown rapidly in recent years. It will grow from $16.11 billion in 2023 to$18.3 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increased R&D investment, expanding disease burden, government funding and support, emergence of contract research organizations (CROs), shift towards personalized medicine, drug repurposing strategies. The drug discovery services market size is expected to see rapid growth in the next few years. It will grow to $30.1 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to regulatory framework changes, advancements in drug delivery systems, increasing interest in immunotherapy, shift towards RNA-based therapeutics, targeting rare diseases. Major trends in the forecast period include advanced technologies adoption, biologicals and biopharmaceuticals growth, adoption of high-throughput screening, advancements in virtual screening, regenerative medicine focus.
Global Drug Discovery Services Market Key Driver
The growing focus on drug discovery trials is expected to propel the drug discovery services market. The drug development life cycle is critical for ensuring safe and effective drug delivery. Due to this, clinical trials are gaining prominence as an essential component of drug development. With the increasing importance of drug development and innovation in healthcare, the demand for drug discovery trials worldwide has increased. For instance, according to ClinicalTrials.gov, a platform for registering clinical trials, the total number of clinical trials reported until 2020 was 325,771 in March 2021, rising to 362,501 in 2021. Therefore, the growing focus on drug discovery trials will drive the growth of the drug discovery services market. The 2023, 2024, and 2028 market sizes for the drug discovery services market correspond to the increasing investment in drug development research and clinical trials, with sustained growth expected as pharmaceutical companies and research organizations seek to address unmet medical needs and introduce new therapeutic interventions.
Get A Free Sample Of The Global Drug Discovery Services Market ReportGlobal Drug Discovery Services Market Segments
The global drug discovery services market covered in this report is segmented –
1) By Type: Chemistry Services, Biology Services
2) By Process: Target Selection, Target Validation, Hit-to-Lead identification, Lead Optimization, Candidate Validation
3) By Drug Type: Biologics Drug , Small Molecule Drug
4) By End user: Pharmaceutical and Biotechnology Companies, Academic Institutes, Other End Users
By Geography: The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa.
North America was the largest region in the drug discovery services market in 2023. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Drug Discovery Services Industry Players
Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company
Get The Full Global Drug Discovery Services Market Report
Drug Discovery Services Market Overview
Drug discovery services refer to the procedure for identifying potential new medicines. It combines many scientific disciplines, including biology, chemistry, and pharmacology. These drug discovery services are offered in four stages: early drug discovery, pre-clinical phase, clinical phases, and regulatory approval.
Drug Discovery Services Global Market Report 2023 provides data on the global drug discovery services market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The drug discovery services market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.